Respiratory / COVID-19
COVID-19, CORONAVIRUS AND ACUTE RESPIRATORY DISTRESS SYNDROME took millions of our loved ones and continues to kill thousands every day. While many will suffer a minor viral infection, tens of thousands will end up hospitalized with COVID-19, struggling to breathe.
All Patients with Critical COVID-19, in the ICU, have Acute Respiratory Distress (ARDS), leaving them struggling to breathe, and at greater risk of death. Currently, there are only very limited medicine options for Critical COVID-19 patients suffering with respiratory failure, leaving physicians with the need for new medicines to help them bring those suffering the worst of COVID-19, an easier and healthier breath.
NRx is evaluating the best path forward for ZYESAMI® as a potential treatment option for Critical COVID-19 and other potential respiratory disorders.